Tema Cardiovascular and M... (HRTS)
NASDAQ: HRTS
· Real-Time Price · USD
29.21
0.02 (0.07%)
At close: Aug 19, 2025, 3:37 PM
29.15
-0.22%
After-hours: Aug 19, 2025, 04:10 PM EDT
0.07% (1D)
| Bid | 20.66 |
| Market Cap | 46.91M |
| AUM | 47.72M |
| NAV | 28.4 |
| EPS (ttm) | 1.16 |
| PE Ratio (ttm) | 25.20 |
| Shares Out | 1.61M |
| Inception Date | Nov 20, 2023 |
| Ask | 37.49 |
| Volume | 520 |
| Open | 29.18 |
| Previous Close | 29.19 |
| Day's Range | 29.11 - 29.25 |
| 52-Week Range | 25.32 - 35.59 |
| Holdings | 43 |
| Expense Ratio | 0.75% |
About HRTS
The actively managed Tema Heart & Health ETF seeks to provide long-term growth of capital by investing in GLP-1 and weight loss companies leading the fight against obesity and cardiometabolic diseases.
Asset Class Equity
Ticker Symbol HRTS
Inception Date Nov 20, 2023
Provider Other
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 43.17% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | LLY | 7.36% |
| Abbott Laboratories | ABT | 5.08% |
| Astrazeneca Plc | AZN.L | 4.41% |
| Roche Holding Ag | RHHBY | 4.27% |
| Unitedhealth Group I... | UNH | 4.05% |
| Gilead Sciences, Inc... | GILD | 3.80% |
| Medtronic Plc | MDT | 3.67% |
| Boston Scientific Co... | BSX | 3.61% |
| Abbvie Inc. | ABBV | 3.57% |
| Novo Nordisk A/s | NOVO-B.CO | 3.35% |
Dividends Dividend Yield 1.46%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 11, 2024 | $0.4693 | Dec 12, 2024 |
